Hospital-acquired pneumonia: Diagnostic strategies: Lessons from clinical trials

Infectious Disease Clinics of North America

Volumn 17, Issue 4, 2003, Pages 717-726

  Fagon, Jean Yves ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CLINICAL TRIAL; DEVICE INFECTION; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FIBEROPTIC BRONCHOSCOPY; HOSPITAL INFECTION; HUMAN; LUNG BIOPSY; LUNG LAVAGE; PATHOGENESIS; PNEUMONIA; REVIEW; VENTILATOR;

EID: 1042301040     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(03)00071-0     Document Type: Review

References (33)

1. Niederman M.S., Torres A., Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med. 150:1994;565-569.
2. Chastre J., Fagon J.Y. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia. Am J Respir Crit Care Med. 150:1994;570-574.
3. Craven D.E., Steger K.A. Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996. Semin Respir Infect. 11:1996;32-53.
4. Johanson W.G., Pierce A.K., Sanford J.P., Thomas G.D. Nosocomial respiratory infections with gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 77:1972;701-706.
5. Garrouste-Orgeas M., Chevret S., Arlet G., Marie O., Rouveau M., Popoff N., et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients: a prospective study based on genomic DNA analysis. Am J Respir Crit Care Med. 156:1997;1647-1655.
6. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 165:2002;867-903.
7. Andrews C.P., Coalson J.J., Smith J.D., Johanson W.G. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest. 80:1981;254-258.
8. Meduri G.U., Mauldin G.L., Wunderink R.G., Leeper K.V. Jr., Jones C.B., Tolley E., et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 106:1994;221-235.
9. Wunderink R.G., Woldenberg L.S., Zeiss J., Day C.M., Ciemins J., Lacher D.A. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest. 101:1992;458-463.
10. Baselski V. Microbiologic diagnosis of ventilator-associated pneumonia. Infect Dis Clin North Am. 7:1993;331-357.
11. Kollef M.H. Ventilator-associated pneumonia: a multivariate analysis. JAMA. 270:1993;1965-1970.
12. McGowan J.E. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 5:1983;1033-1048.
13. Kollef M.H., Sherman G., Ward S., Fraser V.J. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest. 115:1999;462-474.
14. Iregui M., Ward S., Sherman G., Fraser V.J., Kollef M.H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest. 122:2002;262-268.
15. Celis R., Torres A., Gatell J.M., Almela M., Rodriguez-Roisin R., Agusti-Vidal A. Nosocomial pneumonia: a multivariate analysis of risk and prognosis. Chest. 93:1988;318-324.
16. Hanberger H., Garcia-Rodriguez J.A., Gobernado M., Goossens H., Nilsson L.E., Struelens M.J. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA. 281:1999;67-71.
17. Trouillet J.L., Chastre J., Vuagnat A., Joly-Guillou M.L., Combaux D., Dombret M.C., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 157:1998;531-539.
18. Fagon J.Y., Chastre J., Domart Y., Trouillet J.L., Pierre J., Darne C., et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 139:1989;877-884.
19. Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 104:1993;1230-1235.
20. Waterer G.W., Wunderink R.G. Controversies in the diagnosis of ventilator-associated pneumonia. Med Clin North Am. 85:2001;1565-1581.
21. Singh N., Rogers P., Atwood C.W., Wagener M.M., Yu V.L. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: a proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 162:2000;505-511.
22. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis. 143:1991;1121-1129.
23. Heyland D.K., Cook D.J., Marshall J., Heule M., Guslits B., Lang J., et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest. 115:1999;1076-1084.
24. Sole-Violan J., Fernandez J.A., Benitez A.B., Cardenosa Cendrero J.A., Rodriquez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 28:2000;2737-2741.
25. Fagon J.Y., Chastre J., Wolff M., Gervais C., Parer-Aubas S., Stephan F., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med. 132:2000;621-630.
26. Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P.M. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. Am Rev Respir Dis. 143:1991;1121-1129.
27. Heyland D.K., Cook D.J., Marshall J., Heule M., Guslits B., Lang J., et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Canadian Critical Care Trials Group. Chest. 115:1999;1076-1084.
28. Sole-Violan J., Fernandez J.A., Benitez A.B., Cardenosa Cendrero J.A., Rodriguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 28:2000;2737-2741.
29. Fagon J.Y., Chastre J., Wolff M., Gervais C., Parer-Aubas S., Stephan F., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial. Ann Intern Med. 132:2000;621-630.
30. Sanchez-Nieto J.M., Torres A., Garcia-Cordoba F., El-Ebiary M., Carrillo A., Ruiz J., et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med. 157:1998;371-376.
31. Ruiz M., Torres A., Ewig S., Marcos M.A., Alcon A., Lledo R., et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med. 162:2000;119-125.
32. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 153:1996;1711-1725.
33. Hubmayr R.D. Statement of the 4th International Consensus Conference in Critical Care on ICU-acquired Pneumonia. Intensive Care Med. 28:2002;1521-1536.